106 related articles for article (PubMed ID: 22782187)
21. Venous thromboembolism associated with pregnancy and hormonal therapy.
Jacobsen AF; Sandset PM
Best Pract Res Clin Haematol; 2012 Sep; 25(3):319-32. PubMed ID: 22959548
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
[TBL] [Abstract][Full Text] [Related]
23. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
[TBL] [Abstract][Full Text] [Related]
24. Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia.
Livesey JA; Manning RA; Meek JH; Jackson JE; Kulinskaya E; Laffan MA; Shovlin CL
Thorax; 2012 Apr; 67(4):328-33. PubMed ID: 22169361
[TBL] [Abstract][Full Text] [Related]
25. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
26. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.
Goldenberg NA; Knapp-Clevenger R; Manco-Johnson MJ;
N Engl J Med; 2004 Sep; 351(11):1081-8. PubMed ID: 15356305
[TBL] [Abstract][Full Text] [Related]
27. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
[TBL] [Abstract][Full Text] [Related]
28. Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study.
Martinelli I; De Stefano V; Carobbio A; Randi ML; Santarossa C; Rambaldi A; Finazzi MC; Cervantes F; Arellano-Rodrigo E; Rupoli S; Canafoglia L; Tieghi A; Facchini L; Betti S; Vannucchi AM; Pieri L; Cacciola R; Cacciola E; Cortelezzi A; Iurlo A; Pogliani EM; Elli EM; Spadea A; Barbui T
Am J Hematol; 2014 Nov; 89(11):E200-5. PubMed ID: 25042466
[TBL] [Abstract][Full Text] [Related]
29. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
30. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
31. Circulating microparticles and risk of venous thromboembolism.
Bucciarelli P; Martinelli I; Artoni A; Passamonti SM; Previtali E; Merati G; Tripodi A; Mannucci PM
Thromb Res; 2012 May; 129(5):591-7. PubMed ID: 21908018
[TBL] [Abstract][Full Text] [Related]
32. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).
Tsai AW; Cushman M; Rosamond WD; Heckbert SR; Tracy RP; Aleksic N; Folsom AR
Am J Med; 2002 Dec; 113(8):636-42. PubMed ID: 12505113
[TBL] [Abstract][Full Text] [Related]
33. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
Hari P; Prasad Chemiti GK; Lankipalli RS
N Engl J Med; 2000 Dec; 343(26):1968-9. PubMed ID: 11186673
[No Abstract] [Full Text] [Related]
34. Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels.
Legnani C; Cini M; Cosmi B; Poggi M; Boggian O; Palareti G
Haematologica; 2004 Nov; 89(11):1347-51. PubMed ID: 15531457
[TBL] [Abstract][Full Text] [Related]
35. Procoagulant factors and the risk of myocardial infarction in young women.
Tanis B; Algra A; van der Graaf Y; Helmerhorst F; Rosendaal F
Eur J Haematol; 2006 Jul; 77(1):67-73. PubMed ID: 16608503
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy.
Sarig G; Aberbach I; Schliamser L; Blumenfeld Z; Brenner B
Thromb Haemost; 2006 Nov; 96(5):578-83. PubMed ID: 17080213
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for venous thromboembolism in pre-and postmenopausal women.
Bergendal A; Bremme K; Hedenmalm K; Lärfars G; Odeberg J; Persson I; Sundström A; Kieler H
Thromb Res; 2012 Oct; 130(4):596-601. PubMed ID: 22704078
[TBL] [Abstract][Full Text] [Related]
38. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.
Andreescu AC; Cushman M; Rosendaal FR
Thromb Haemost; 2002 Jan; 87(1):47-51. PubMed ID: 11858188
[TBL] [Abstract][Full Text] [Related]
39. Hormonal state rather than age influences cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency.
Liberti G; Bertina RM; Rosendaal FR
Thromb Haemost; 1999 Sep; 82(3):1093-6. PubMed ID: 10494769
[TBL] [Abstract][Full Text] [Related]
40. [Venous thromboembolic pathology. New acquired risk factors or new data on acquired risk factors].
Drouet L
Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1318-26. PubMed ID: 11794976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
